Back
Neurocrine Biosciences, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
52
NBIX
Neurocrine Biosciences, Inc.
Last Price:
$122.87
Seasonality Move:
-5.2%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIX is experiencing slight buying pressure.
Neurocrine Biosciences, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 138.53 | Sell |
| 20-day SMA: | 136.5 | Buy |
| 50-day SMA: | 142.07 | Sell |
| 200-day SMA: | 135.46 | Buy |
| 8-day EMA: | 138.07 | Sell |
| 20-day EMA: | 137.81 | Sell |
| 50-day EMA: | 139.72 | Sell |
| 200-day EMA: | 136.64 | Buy |
Neurocrine Biosciences, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.38 | Sell |
| Relative Strength Index (14 RSI): | 48.11 | Sell |
| Chaikin Money Flow: | 8660 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (133.86 - 138.68) | Buy |
| Bollinger Bands (100): | (136.13 - 148.69) | Sell |
Neurocrine Biosciences, Inc. Technical Analysis
| Jan 29 | Jan 30 | Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | |||||||||
| 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Neurocrine Biosciences, Inc. Stock
Is Neurocrine Biosciences, Inc. Stock a Buy?
-
Neurocrine Biosciences, Inc. share price is 137.44 while NBIX 8-day simple moving average is 138.53, which is a Sell signal.
-
The stock price of NBIX is 137.44 while Neurocrine Biosciences, Inc. 20-day SMA is 136.50, which makes it a Buy.
-
Neurocrine Biosciences, Inc. 50-day simple moving average is 142.07 while NBIX share price is 137.44, making it a Sell technically.
-
NBIX stock price is 137.44 and Neurocrine Biosciences, Inc. 200-day simple moving average is 135.46, creating a Buy signal.
NBIX Technical Analysis vs Fundamental Analysis
Buy
52
Neurocrine Biosciences, Inc. (NBIX)
is a Buy
Is Neurocrine Biosciences, Inc. a Buy or a Sell?
-
Neurocrine Biosciences, Inc. stock is rated a BuyThe current Neurocrine Biosciences, Inc. [NBIX] share price is $137.44. The Score for NBIX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Neurocrine Biosciences, Inc. Stock Info
Market Cap:
13.7B
Price in USD:
137.44
Share Volume:
1.4M
Neurocrine Biosciences, Inc. 52-Week Range
52-Week High:
160.18
52-Week Low:
84.23
Buy
52
Neurocrine Biosciences, Inc. (NBIX)
is a Buy
Neurocrine Biosciences, Inc. Share Price Forecast
-
What is the Neurocrine Biosciences, Inc. stock price today?The Neurocrine Biosciences, Inc. stock price is 137.44 USD today.
-
Will NBIX stock go up or go down?Neurocrine Biosciences, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Neurocrine Biosciences, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Neurocrine Biosciences, Inc. is not overvalued.
Is Neurocrine Biosciences, Inc. Stock a Buy?
-
Neurocrine Biosciences, Inc. share price is 137.44 while NBIX 8-day exponential moving average is 138.07, which is a Sell signal.
-
The stock price of NBIX is 137.44 while Neurocrine Biosciences, Inc. 20-day EMA is 137.81, which makes it a Sell.
-
Neurocrine Biosciences, Inc. 50-day exponential moving average is 139.72 while NBIX share price is 137.44, making it a Sell technically.
-
NBIX stock price is 137.44 and Neurocrine Biosciences, Inc. 200-day simple moving average is 136.64, creating a Buy signal.
Fundamental Analysis of Neurocrine Biosciences, Inc.
Is Neurocrine Biosciences, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.33 per share, and an increase next year of $1.58 per share.
Technical Analysis of Neurocrine Biosciences, Inc.
Should I short Neurocrine Biosciences, Inc. stock?
-
NBIX Moving Average Covergence Divergence (MACD) indicator is -0.38, suggesting Neurocrine Biosciences, Inc. is a Sell
-
Neurocrine Biosciences, Inc. Relative Strength Index (RSI) is 48.11, which suggest Neurocrine Biosciences, Inc. is oversold
-
The Bollinger Bands (25) for Neurocrine Biosciences, Inc. is (133.86 - 138.68), which suggest Neurocrine Biosciences, Inc. is a Sell
-
The Bollinger Bands (100) for Neurocrine Biosciences, Inc. is (136.13 - 148.69), which suggest Neurocrine Biosciences, Inc. is a Sell
* Neurocrine Biosciences, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.